Role of folic acid supplementation in level of c-reactive protein in metabolic syndrome
evidence based case report
Abstract
Introduction: The prevalence of metabolic syndrome is increasing, its progression involves an inflammatory response that has an important impact on the initiation, progressivity, and complications of several diseases such as heart disease, stroke, type 2 diabetes mellitus, and cancer. C-reactive protein (CRP) is one of the inflammation markers increased in patients with metabolic syndrome. Folic acid has a role in metabolizing homocysteine and improving endothelial function. There have been many studies conducted, but the results are still inconsistent. Method: Literature searching was conducted using PubMed, Cochrane Library, and Embase databases. MeSH terms, advanced search and eligibility criteria were used for title/abstract screening before journal review. Results: One systematic review and meta-analysis (SR-MA) and one RCT met the PICO and eligibility criteria. The SR-MA found that folic acid administration can reduce CRP level (WMD -0.94 (95% CI -1.56 – 0.32; p=0.00) at a dose of 0.15 mg/day for 12 weeks to 10 mg/day for 2 weeks, while the RCT found an insignificant result. Conclusion: Folic acid supplementation has a potential benefit to decrease CRP levels in metabolic syndrome.Downloads
References
Li, W. Qiu, X. Ma, H. Geng, Q. Incidence and long-term specific mortality trends of metabolic syndrome in the United States. Frontiers in Endocrinology. 2023; p. 4.
Sigit FS, et al. The prevalence of metabolic syndrome and its association with body fat distribution in middle-aged individuals from Indonesia and the Netherlands: a cross-sectional analysis of population-based studies. Diabetol Metab Syndr. 2020; p. 4.
Arifin H, Chou KR, Ibrahim K, Fitri SUR, Pradipta RO, Rias YA, et al. Analysis of modifiable, non-modifiable, and physiological risk factors of non-communicable diseases in Indonesia: Evidence from the 2018 Indonesian Basic Health Research. Journal of Multidisciplinary Healthcare. 2022; p. 2204.
Asbaghi O, et al. Effects of folic acid supplementation on inflammatory markers: A grade-assessed systematic review and dose-response meta-analysis of randomized controlled trials. Nutrients. 2021; p. 2.
Ridker PM, Buring JE, Cook NR, Rifai N. C-Reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. Circulation. 2003; p. 393.
Talari HR, et al. The effects of folate supplementation on carotid intima-media thickness and metabolic status in patients with metabolic syndrome. Ann Nutr Metab; 2016; p. 45.
Spoelstra M, et al. No effect of folic acid on markers of endothelial dysfunction or inflammation in patiens with type 2 diabetes mellitus and mild hyperhomocysteinaemia. Neth J Med. 2004; p. 1.
Jiang Z, Qu H, Chen K, Gao Z. Beneficial effects of folic acid on inflammatory markers in the patient with metabolic syndrome: Meta-analysis and meta-regression of data from 511 participants in 10 randomized controlled trials. Crit Rev in Food Sci and Nutr. 2022; p. 2.
Schneider MP, et al. Folic acid treatment normalizes NOS-dependence of vascular tone in the metabolic syndrome. Obesity. 2011; p. 963.
Devaraj S, Singh U, Jialal I. Human C-reactive protein and the metabolic syndrome. Curr Opin Lipidol. 2009; p. 185.
Prasad, K. C-Reactive protein-lowering agents. Cardiovascular Drug Reviews. 2006; p. 43.
Antonopoulos AS, Margaritis M, Lee R, Channon K, Antoniades C. Statins as anti-inflammatory agents in atherogenesis: Molecular mechanisms and lessons from the recent clinical trials. Current Pharmaceutial Design. 2012; p. 1519.
Gropper SS, Smith JL, Carr, TP. Advanced Nutrition and Human Metabolism 8th Edition. Cengage. 2022; p. 370.
Submitted
Copyright (c) 2024 Anissa Syafitri Sjarkowi, Yohannessa Wulandari, Trismiyanti Trismiyanti
This work is licensed under a Creative Commons Attribution 4.0 International License.
World Nutrition Journal is an open acces journal and under the licence of
